Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The mechanism of apoptosis has been extensively characterized over the past decade, but little is known about alternative forms of regulated cell death. Although stimulation of the Fas/TNFR receptor family triggers a canonical 'extrinsic' apoptosis pathway, we demonstrated that in the absence of intracellular apoptotic signaling it is capable of activating a common nonapoptotic death pathway, which we term necroptosis. We showed that necroptosis is characterized by necrotic cell death morphology and activation of autophagy. We identified a specific and potent small-molecule inhibitor of necroptosis, necrostatin-1, which blocks a critical step in necroptosis. We demonstrated that necroptosis contributes to delayed mouse ischemic brain injury in vivo through a mechanism distinct from that of apoptosis and offers a new therapeutic target for stroke with an extended window for neuroprotection. Our study identifies a previously undescribed basic cell-death pathway with potentially broad relevance to human pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Necroptosis is a form of RCD initiated by perturbations of the extracellular or intracellular microenvironment detected by specific death receptors, including (but not limited to) FAS and TNFR1 [423–427], or pathogen recognition receptors (PRRs), including TLR3, TLR4, and Z-DNA binding protein 1 (ZBP1; also known as DAI) [428–430].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
In the citing paper
“Accordingly, chemical inhibitors of RIPK1 including necrostatin-1 (Nec-1) and derivatives (e.g., Nec-1s) robustly inhibit TNFR1-driven necroptosis, in vitro and in vivo [425, 427].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Self-citationAutophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608 · cited 1×
“Activation of autophagy by necroptotic signaling Autophagy, a large-scale protein degradation and catabolic mechanis”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 1×
“4e and data not shown), in autophagy-deficient Atg5 −/− MEF cell”
Self-citationHoller, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Self-citationGrowth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y., & Yoshimori, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01131 · Cited by 1,394
Self-citationAutophagy as a cell death and tumor suppressor mechanism
Gozuacik, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,384 · cited 1×
“, has been implicated in caspase-independent cell deat”
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312 · cited 10×
“2f), whereas it completely inhibited the appearance of necrotic morphology (nuclear condensation, organelle swelling, early loss of plasma membrane integrity and Nec-1 0 20 40 60 80 100 V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% )…”
InfluentialIntracellular ATP levels determine cell death fate by apoptosis or necrosis.
Eguchi, Y., Shimizu, S., & Tsujimoto, Y. (1997) · PubMed · Cited by 1,243
Cited by
Items 601–700 of 1,015
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)
Iturbe-Rey, S., Maccali, C., Arrese, M. A., Aspichueta, P., de Oliveira, C. P. M. S., Castro, R. E., Lapitz, A., Izquierdo‐Sánchez, L., Bujanda, L., Perugorria, M. J., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119053 · Cited by 130
Necroptosis-Inducing Rhenium(V) Oxo Complexes
Suntharalingam, K., Awuah, S. G., Bruno, P. M., Johnstone, T. C., Wang, F., Wei, L., Zheng, Y., Page, J. E., Hemann, M. T., & Lippard, S. J. (2015) · Journal of the American Chemical Society · doi:10.1021/ja511978y · Cited by 104
Liu, W., Chen, B., Wang, Y., Meng, C., Huang, H., Huang, X., Qin, J., Mulay, S. R., Anders, H., Qiu, A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716959115 · Cited by 105
“Necroptosis has also been shown to contribute to the pathogenesis of ischemic injury in the brain, heart, and kidney (5, 6, 8, 32, 33), atherosclerosis (34), pancreatitis (14), inflammatory bowel diseases (35), and viral infection (36).”
BackgroundNecroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance
Lin, S., Hsieh, S., Fan, Y.-T., Wei, W., Hsiao, P., Tsai, D.-H., Wu, T., & Yang, N. (2017) · Autophagy · doi:10.1080/15548627.2017.1386359 · Cited by 98
Tang, Y., Tu, H., Zhang, J., Zhao, X., Wang, Y., Qin, J., & Lin, X. (2019) · Nature Communications · doi:10.1038/s41467-019-12033-8 · Cited by 106
Regulation of programmed cell death by Brd4
Hu, J., Pan, D., Guo, L., Chen, K., & Hu, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05505-1 · Cited by 105
Therapeutic exploitation of necroptosis for cancer therapy
Fulda, S. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.07.002 · Cited by 106
Going up in flames: necrotic cell injury and inflammatory diseases
Challa, S., & Chan, F. K.-M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0413-8 · Cited by 96
“Necrostatin- 1 specifically inhibits the pro-necrotic RIP1 kinase activity, but not the kinase activities of other kinases including RIP2 and RIP3 [75, 76].”
Transition‐Metal‐Catalyzed Regioselective Alkylation of Indoles with Alcohols
Putra, A. E., Takigawa, K., Tanaka, H., Ito, Y., Oe, Y., & Ohta, T. (2013) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201300744 · Cited by 96
Su, X., Wang, H., Kang, D., Zhu, J., Sun, Q., Li, T., & Ding, K. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1510-0 · Cited by 100
Necroptosis mediates myofibre death in dystrophin-deficient mice
Morgan, J. E., Prola, A., Mariot, V., Pini, V., Meng, J., Hourdé, C., Dumonceaux, J., Conti, F. J. A., Relaix, F., Authier, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06057-9 · Cited by 114
Targeting necroptosis in anticancer therapy: mechanisms and modulators
Wu, Y., Dong, G., & Sheng, C. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.01.007 · Cited by 109
Ferroptosis and kidney disease
Martín‐Sánchez, D., Fontecha‐Barriuso, M., Martinez-Moreno, J. M., Ramos, A. M., Sánchez-Niño, M. D., Guerrero‐Hue, M., Moreno, J. A., Ortíz, A., & Sanz, A. B. (2020) · Nefrología · doi:10.1016/j.nefro.2020.03.005 · Cited by 105
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation
Xu, G., Li, Y., Zhang, S., Peng, H., Wang, Y., Li, D., Jin, T., He, Z., Tong, Y., Qi, C., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00578-7 · Cited by 110
Self-citationNew tricks of an old molecule: lifespan regulation by p53
Bauer, J. H., & Helfand, S. L. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00228.x · Cited by 105
Role of Atg5-dependent cell death in the embryonic development of Bax/Bak double-knockout mice
Arakawa, S., Tsujioka, M., Yoshida, T., Tajima-Sakurai, H., Nishida, Y., Matsuoka, Y., Yoshino, I., Tsujimoto, Y., & Shimizu, S. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.84 · Cited by 94
Zhang, Q., Zhang, Y., Zhang, P., 晁振华, Xia, F., Jiang, C., Zhang, X., Jiang, Z., & Liu, H. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.9 · Cited by 101
“Necroptosis is a regulated necrotic cell death triggered by broad caspase inhibition and is characterized by necrotic cell death morphology and the activation of autophagy [15].”
BackgroundChen, S.-Y., Chiu, L.-Y., Ma, M.-C., Wang, J.-S., Chien, C.-L., & Lin, W.-W. (2011) · Autophagy · doi:10.4161/auto.7.2.14212 · Cited by 93
Markovinović, A., Cimbro, R., Ljutić, T., Križ, J., Rogelj, B., & Munitić, I. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.04.005 · Cited by 100
RIPK protein kinase family: Atypical lives of typical kinases
Cuny, G. D., & Degterev, A. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.06.014 · Cited by 103
“The first reported inhibitor of this kinase family did not emerge from a kinase screen, but rather a phenotypic cell-based screen seeking to identify compounds that would block necroptosis in an assay of TNFα-induced cell death in FADDdeficient Jurkat cells [8].”
BackgroundSelf-citationRIPK3 signaling and its role in regulated cell death and diseases
Zhou, Y., Xiang, Y., Liu, S., Li, C., Dong, J., Kong, X., Ji, X., Cheng, X., & Zhang, L. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01957-w · Cited by 109
“However, extensive research in the fi eld of cell death has revealed that necrosis can be regulated in a programmed manner through a signaling pathway called necroptosis [2, 3].”
RNA interference-mediated downregulation of Beclin1 attenuates cerebral ischemic injury in rats
Zheng, Y.-Q., Liu, J.-X., Li, X.-Z., Xu, L., & Xu, Y.-G. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.79 · Cited by 94
Chemical probing reveals insights into the signaling mechanism of inflammasome activation
Gong, Y., Wang, X., Wang, J., Yang, Z., Li, S., Yang, J., Liu, L., Lei, X., & Shao, F. (2010) · Cell Research · doi:10.1038/cr.2010.135 · Cited by 105
Hawk, M. A., Gorsuch, C. L., Fagan, P., Lee, C., Kim, S. E., Hamann, J. C., Mason, J. A., Weigel, K. J., Tsegaye, M. A., Shen, L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0034-2 · Cited by 99
A novel TNFR1-triggered apoptosis pathway mediated by class IA PI3Ks in neutrophils
Geering, B., Gurzeler, U., Federzoni, E., Kaufmann, T., & Simon, H.-U. (2011) · Blood · doi:10.1182/blood-2010-11-322206 · Cited by 91
Yamanaka, K., Urano, Y., Takabe, W., Saito, Y., & Noguchi, N. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.524 · Cited by 96
“Necroptosis is further defined as being inhibited by Necrostatin-1 (Nec-1), a specific inhibitor of RIPK1 kinase activity.(3) Interestingly, necroptosis can be induced by apoptosis-inducing ligands such as Fas ligand or tumor necrosis factor a (TNFa).”
BackgroundHuang, X., Feng, Y., Xiong, G., Whyte, S. K., Duan, J., Yang, Y., Wang, K., Yang, S., Geng, Y., Ou, Y., et al. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0292-0 · Cited by 101
Necroptosis pathways in tumorigenesis
Zhang, T., Wang, Y., Inuzuka, H., & Wei, W. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.07.007 · Cited by 105
Autophagy in acute brain injury: Feast, famine, or folly?
Smith, C. M., Chen, Y., Sullivan, M. L., Kochanek, P. M., & Clark, R. S. B. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.014 · Cited by 93
Regulated cell death pathways: New twists in modulation of BCL2 family function
Sasi, N., Hwang, M., Jaboin, J. J., Csiki, I., & Lu, J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0895 · Cited by 105
“Studies have found that the inhibition of necrosis by agents such as necrostatin-1 has been beneficial for certain diseases and injuries, such as brain ischemia (10).”
BackgroundInfluentialZhou, X.-Y., Luo, Y., Zhu, Y.-M., Liu, Z.-H., Kent, T. A., Rong, J., Li, W., Qiao, S.-G., Li, M., Ni, Y., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.34 · Cited by 95
Martens, S., Jeong, M., Tonnus, W., Feldmann, F., Hofmans, S., Goossens, V., Takahashi, N., Bräsen, J. H., Lee, E., der Veken, P. V., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.298 · Cited by 96
“Dose-response curves and IC50 values for the potency of Sorafenib to inhibit cell death, were determined and compared with Nec-1s, as a reference compound.(22) As for murine cells, L929sAhFas and MEF cells stimulated with mTNF or with mTNF/smac mimetic BV6/zVAD-fmk (Figures 2a and b), Sorafenib inhibited necroptosis w…”
MethodCaspase Inhibitors Protect Neurons by Enabling Selective Necroptosis of Inflamed Microglia
Fricker, M., Vilalta, A., Tolkovsky, A. M., & Brown, G. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.427880 · Cited by 92
“Necrostatin-1 was first discovered in a screen for regulators of necrotic death, and its death inhibiting activity is wholly dependent on inhibition of RIPK-1 activity (9, 11, 28).”
BackgroundZhao, H., Chen, H., Guo, Z., Zhang, W., Yu, H., Zhuang, Z., Zhong, H., & Liu, Z. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.124314 · Cited by 95
Zhao, P., Wei, Y., Sun, G., Xu, L., Wang, T., Tian, Y., Chao, H., Tu, Y., & Ji, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02633-5 · Cited by 95
Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death
Clucas, J., & Meier, P. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00623-w · Cited by 105
“All small-molecule inhibitors of RIPK1, such as Nec-1s, GSK2982772 and DNL747, bind to this pocket and prevent the conformational rearrangement of the N-lobe and C-lobe as well as the backside of the kinase domain 20,45,174–176 (Box 1).”
BackgroundLiu, D., Qin, H., Gao, Y., Sun, M., & Wang, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107258 · Cited by 105
Redox signaling in the pancreas in health and disease
Sastre, J., Pérez, S., Sabater-Orti, L., & Rius‐Pérez, S. (2024) · Physiological Reviews · doi:10.1152/physrev.00044.2023 · Cited by 111
p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases
Liu, Y., Stockwell, B. R., Jiang, X., & Gu, W. J. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00842-3 · Cited by 111
Frontier of Epilepsy Research - mTOR signaling pathway
Cho, C.-H. (2011) · Experimental and Molecular Medicine · doi:10.3858/emm.2011.43.5.032 · Cited by 93
“It remains to be seen how RIP1 and RIP3 interact with each other in epilepsy, and whether a specific inhibitor, necrostatin-1 prevents epilepsy-induced cell death (Degterev et al., 2005).”
BackgroundKhan, N. R., Lawlor, K. E., Murphy, J. M., & Vince, J. E. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.10.017 · Cited by 98
RIP kinase 1–dependent endothelial necroptosis underlies systemic inflammatory response syndrome
Zelic, M., Roderick, J. E., O’Donnell, J. A., Lehman, J. W., Lim, S. E., Janardhan, H. P., Trivedi, C. M., Pasparakis, M., & Kelliher, M. A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96147 · Cited by 97
“RIPK1 kinase–dependent effects were initially interrogated using the small molecule inhibitor of RIPK1 kinase activity, Necrostatin-1 (Nec-1) (17, 18); however, interpreting these in vivo studies was limited by compound instability and off-target effects (19).”
MethodStructure–activity relationship study of a novel necroptosis inhibitor, necrostatin-7
Zheng, W., Degterev, A., Hsu, E., Yuan, J., & Yuan, C. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.058 · Cited by 92
Self-citationIdentification of Small Molecule Inhibitors of Phosphatidylinositol 3-Kinase and Autophagy
Farkas, T., Daugaard, M., & Jäättelä, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.269134 · Cited by 91
The Role of Regulated Programmed Cell Death in Osteoarthritis: From Pathogenesis to Therapy
Liu, S., Pan, Y., Li, T., Zou, M., Liu, W., Li, Q., Wan, H., Peng, J., & Hao, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065364 · Cited by 105
“Necroptosis, which is mediated by Receptor-interacting serine/threonine-protein kinase 1(RIPK1) and Receptor-interacting serine/threonine-protein kinase 3(RIPK3), has a mechanism similar to that of apoptosis and a morphology similar to that of necrosis [81,82].”
BackgroundNecrostatin-1 protection of dopaminergic neurons
Cheng, Y.-B., Wu, J.-R., Wang, J., Zhou, S.-K., Yang, L., Yin, J.-L., & Cao, J.-P. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.160108 · Cited by 90
“Necrostatin-1 (Nec-1) was discovered to be a specific inhibitor of this pathway (Degterev et al., 2005).”
Background5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma
Coupienne, I., Fettweis, G., Rubio, N., Agostinis, P., & Piette, J. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05213f · Cited by 91
Hoshino, M., Qi, M.-L., Yoshimura, N., Miyashita, T., Tagawa, K., Wada, Y.-I., Enokido, Y., Marubuchi, S., Harjes, P., Arai, N., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200509132 · Cited by 90
“It is noteworthy that Degterev et al. (2005) has recently reported a new type of cell death—necroptosis.”
BackgroundMixed Lineage Kinase Domain-like Protein MLKL Breaks Down Myelin following Nerve Injury
Ying, Z., Pan, C., Shao, T., Liu, L., Li, L., Guo, D., Zhang, S., Yuan, T., Cao, R., Jiang, Z., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.09.011 · Cited by 98
“Kinases that Activate MLKL The phosphorylation of MLKL S441 in Schwann cells occurs independently of the MLKL phosphorylation known to occur during necroptosis; the slowed myelin breakdown phenotype in Mlkl knockout mice was not observed in Rip3 knockout mice (Figure 2), and treatment with inhibitors of RIP1 kinase ac…”
BackgroundZhou, T., Wang, Q., Phan, N., Ren, J. P., Yang, H. M., Feldman, C. C., Feltenberger, J. B., Ye, Z., Wildman, S. A., Tang, W., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1468-6 · Cited by 96
Grievink, H. W., Heuberger, J. A. A. C., Huang, F., Chaudhary, R., Birkhoff, W. A. J., Tonn, G., Mosesova, S., Erickson, R., Moerland, M., Haddick, P. C. G., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1615 · Cited by 94
Innate immune sensing of cell death in disease and therapeutics
Man, S. M., & Kanneganti, T. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01491-y · Cited by 100
“6–9 ) and the effector mixed lineage kinase domain-like pseudoki-nase (MLKL) 10,11 .”
Proliferative versus apoptotic functions of caspase-8
van Raam, B. J., & Salvesen, G. S. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.06.005 · Cited by 90
“and caspase-8 inhibitor CrmA [96] in the cells, revealed that inparticular inhibition of caspase-8 triggered this form of cell death, now generally known as ‘necroptosis’ [93,97,98].”
BackgroundBao, L., Li, Y., Deng, S., Landry, D. W., & Tabas, I. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606339200 · Cited by 90
Self-citationTherapeutic Agents Triggering Nonapoptotic Cancer Cell Death
Kornienko, A., Mathieu, V., Rastogi, S. K., Lefranc, F., & Robert Kiss, A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400136m · Cited by 95
Wang, S., Ni, H.-M., Dorko, K., Kumer, S. C., Schmitt, T. M., Nawabi, A., Komatsu, M., Huang, H., & Ding, W.-X. (2016) · Oncotarget · doi:10.18632/oncotarget.6893 · Cited by 89
The Regulation and Modification of GSDMD Signaling in Diseases
Li, Z., Ji, S., Jiang, M., Xu, Y., & Zhang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.893912 · Cited by 108
“It is demonstrated that not only GSDMD (37) but also NLRC4 and NLRP3 have been identified to promote microglia or neuronal pyroptotic cell death in ischemic stroke (35, 36).”
BackgroundThe Alarmin Properties of DNA and DNA-associated Nuclear Proteins
Magna, M., & Pisetsky, D. S. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.02.029 · Cited by 96
“The ability to curtail death is obviously important in some settings (eg, ischemia, infarction), and agents such as the necrostatins may find clinical utility.(19,20) The availability of the necrostatins, as well as genetically altered cells and animals lacking elements of this pathway, can help elucidate the mechanis…”
BackgroundNecroptosis and neutrophil-associated disorders
Wang, X., Yousefi, S., & Simon, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0058-8 · Cited by 105
Extracellular acidification induces ROS- and mPTP-mediated death in HEK293 cells
Teixeira, J., Basit, F., Swarts, H. G. P., Forkink, M., Oliveira, P. J., Willems, P. H. G. M., & Koopman, W. J. H. (2017) · Redox Biology · doi:10.1016/j.redox.2017.12.018 · Cited by 97
Yang, H., Jiang, H., Tao, J., Zhang, C., Xiong, J., Yang, J., Liu, Y., Zhong, W., Guan, X., Duan, J., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00889-8 · Cited by 94
Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia
Rami, A., Bechmann, I., & Stehle, J. H. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.003 · Cited by 98
White, E. (2008) · Autophagy · doi:10.4161/auto.5907 · Cited by 87
Necroptosis: A new way of dying?
Hanson, B. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1210732 · Cited by 86
“The novel chimera born from apoptosis and necrosis, aptly named necroptosis, occurs by a programmable mechanism with a characteristic necrotic cell death phenotype.(36) The term necroptosis has been used on occasion interchangeably with programmed or regulated necrosis 55-57 but this is too general a description, espe…”
BackgroundCell death in drug-induced liver injury
Iorga, A., & Dara, L. (2019) · Advances in Pharmacology · doi:10.1016/bs.apha.2019.01.006 · Cited by 88
Lu, L., Tian, J., Luo, X., & Peng, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03587-8 · Cited by 91
Huang, H., Jin, W. W., Huang, M., Ji, H., Capen, D. E., Xia, Y. Y., Yuan, J., Păunescu, T. G., & Lu, H. A. J. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020204 · Cited by 94
Self-citationWu, X., Luo, Q., & Liu, Z. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02760-y · Cited by 99
Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?
Bu, Z., Yu, H., Wang, J., He, X., Cui, Y., Feng, J., & Feng, J. (2021) · ASN NEURO · doi:10.1177/17590914211037505 · Cited by 97
“Furthermore, a proportion of neuronal cells die through regulated necrosis termed necroptosis, which is induced after cerebral ischemia (Degterev et al., 2005; Li, Mu, et al., 2020).”
BackgroundNadendla, E. K., Tweedell, R. E., Kasof, G. M., & Kanneganti, T. (2025) · Cell Discovery · doi:10.1038/s41421-025-00791-3 · Cited by 109
ROS homeostasis in cell fate, pathophysiology, and therapeutic interventions
Chen, Y.-S., Tian, H., Rong, D., Wang, L., Chen, S., Zeng, J., Xu, H., Mei, J., Wang, L.-Y., Liou, Y., et al. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00338-8 · Cited by 111
Structure−Activity Relationship Study of Tricyclic Necroptosis Inhibitors
Jagtap, P. G., Degterev, A., Choi, S., Keys, H. R., Yuan, J., & Cuny, G. D. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061016o · Cited by 87
Self-citationNecroptosis Mediates TNF-Induced Toxicity of Hippocampal Neurons
Liu, S., Wang, X., Li, Y., Xu, L., Yu, X., Ge, L., Li, J., Zhu, Y., & He, S. (2014) · BioMed Research International · doi:10.1155/2014/290182 · Cited by 95
“Blockage of necroptosis by necrostatin-1, a chemical inhibitor targeting RIP1 kinase, has provided protective effects on neuronal damage in animal models of brain injury [20], stroke [18], and amyotrophic lateral sclerosis [33].”
BackgroundSelf-citationRegulated Necrosis in Pulmonary Disease. A Focus on Necroptosis and Ferroptosis
Minagawa, S., Yoshida, M., Araya, J., Hara, H., Imai, H., & Kuwano, K. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0337tr · Cited by 97
The possible roles of necroptosis during cerebral ischemia and ischemia / reperfusion injury
Liao, S., Apaijai, N., Chattipakorn, N., & Chattipakorn, S. C. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108629 · Cited by 86
Ye, Y., Yu, L., Wang, H., Tashiro, S., Onodera, S., & Ikejima, T. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11105fp · Cited by 92
Caspase-Independent Programmed Cell Death Following Ischemic Stroke
Cho, B. B., & Toledo-Pereyra, L. H. (2008) · Journal of Investigative Surgery · doi:10.1080/08941930802029945 · Cited by 101
“and programmed, but, as in necrosis, organelles such as mitochondria are swollen and damaged [37].”
BackgroundNecroptosis: A Novel Cell Death Modality and Its Potential Relevance for Critical Care Medicine
Moreno‐González, G., Vandenabeele, P., & Krysko, D. V. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2106ci · Cited by 93
Neutrophil Necroptosis Is Triggered by Ligation of Adhesion Molecules following GM-CSF Priming
Wang, X., He, Z., Liu, H., Yousefi, S., & Simon, H.-U. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600051 · Cited by 86
“Human blood neutrophils were cultured at 1 3 106/ml. Neutrophils were cultured in RPMI 1640 medium plus GlutaMAX (Invitrogen) supplemented with 5% FCS and antibiotics in the presence and absence of GM-CSF (10 ng/ml), anti-FAS (1 mg/ml), PD169316 (10 mM), wortmannin (100 nM), PI103 (100 nM), TGX221 (100 nM), IC87114 (1…”
BackgroundInfluentialBRAF and AXL oncogenes drive RIPK3 expression loss in cancer
Najafov, A., Zervantonakis, I. K., Mookhtiar, A. K., Greninger, P., March, R. J., Egan, R. K., Luu, H. S., Stover, D. G., Matulonis, U. A., Benes, C. H., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005756 · Cited by 93
Self-citationApoptosis-Modulating Drugs for Improved Cancer Therapy
Ocker, M., & Höpfner, M. (2012) · European Surgical Research · doi:10.1159/000336875 · Cited by 96
TRAF2 protects against cerebral ischemia-induced brain injury by suppressing necroptosis
Li, J., Zhang, J., Zhang, Y., Wang, Z., Song, Y., Wei, S., He, M., You, S., Jia, J., & Cheng, J. G. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1558-5 · Cited by 92
Zhou, P., Zhang, S., Wang, M., & Zhou, J. F. (2023) · Biomolecules · doi:10.3390/biom13050820 · Cited by 90
“Necroptosis was first proposed in 2005 as a new mode of programmed cell death [15].”
BackgroundZhu, L., Liu, Y., Wang, K., & Wang, N. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102629 · Cited by 98
Deeraksa, A., Pan, J., Sha, Y., Liu, X.-D., Eissa, N. T., Lin, S.-H., & Yu-Lee, L.-Y. (2012) · Oncogene · doi:10.1038/onc.2012.309 · Cited by 94
“Our observation that Nec-1, a potent inhibitor of RIP1 kinase activity (23, 36), attenuated necroptotic cell death induced by either Plk1 inhibition or Plk1 depletion suggests that the RIP1/RIP3 “necrosome complex” is involved in the activation of necroptosis in LNCaP-AI cells.”
BackgroundMethodLoos, B., Genade, S., Ellis, B., Lochner, A., & Engelbrecht, A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.03.011 · Cited by 87
Zille, M., Kumar, A., Kundu, N., Bourassa, M. W., Wong, V. S. C., Willis, D. E., Karuppagounder, S. S., & Ratan, R. R. (2019) · eNeuro · doi:10.1523/eneuro.0263-18.2019 · Cited by 86
“Necroptosis is another mode of regulated cell death that depends on the activation of receptor-interacting proteins (RIPs; Degterev et al., 2005; Sun et al., 2012).”
BackgroundCell death–mediated cytokine release and its therapeutic implications
Place, D. E., & Kanneganti, T.-D. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181892 · Cited by 84
“IL-1β (canakinumab) IL-1 decoy receptor (rilonacept) de Koning et al., 2015 AOSD IL-1β IL-18?”
Riegger, J., & Brenner, R. E. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1930-5 · Cited by 82
Cell death signalling in virus infection
Imre, G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109772 · Cited by 83
“which is nowadays termed necroptosis [59] [55].”
Josey, B. J., Inks, E. S., Wen, X., & Chou, C. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301485d · Cited by 84
Puyal, J., Ginet, V., Grishchuk, Y., Truttmann, A. C., & Clarke, P. G. H. (2012) · The Neuroscientist · doi:10.1177/1073858411404948 · Cited by 84
Necroptosis is a key mediator of enterocytes loss in intestinal ischaemia/reperfusion injury
Wen, S., Ling, Y., Yang, W., Shen, J., Li, C., Deng, W., Liu, W., & Liu, K. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12987 · Cited by 86
Necroptosis in cardiovascular disease - a new therapeutic target
Gupta, K., Phan, N., Wang, Q., & Liu, B. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.03.003 · Cited by 90
“The effort led to the discovery of Necrostatin 1s (Nec-1s) [6].”
BackgroundInfluentialThe Killer Pseudokinase Mixed Lineage Kinase Domain-Like Protein (MLKL)
Murphy, J. M. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036376 · Cited by 90
Montfort, C. V., Matias, N., Fernandez, A., Fucho, R., de la Rosa, L. C., Martinez-Chantar, M. L., Mato, J. M., Machida, K., Tsukamoto, H., Murphy, M. P., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.024 · Cited by 83
“Moreover, since RIP1 kinase plays a pivotal role in necrotic cell death, we tested the effect of necrostatin-1, a RIP1 kinase inhibitor [27].”
BackgroundInflammasome assembly in neurodegenerative diseases
Singh, J., Habean, M. L., & Panicker, N. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.009 · Cited by 83
Necrosis-dependent and independent signaling of the RIP kinases in inflammation
Moriwaki, K., & Chan, F. K.-M. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.013 · Cited by 93
“[13–17], retinitis [18–20], atherosclerosis [21], and ischemiareperfusion injury in brain, myocardium, and kidney [22–27].”
BackgroundAutophagy in Retinal Ganglion Cells in a Rhesus Monkey Chronic Hypertensive Glaucoma Model
Deng, S., Wang, M., Yan, Z., Tian, Z., Chen, H., Yang, X., & Zhuo, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077100 · Cited by 92
Location, location, location: A compartmentalized view of TNF-induced necroptotic signaling.
Samson, A. L., Garnish, S. E., Hildebrand, J. M., & Murphy, J. M. (2021) · Science Signaling · doi:10.1126/scisignal.abc6178 · Cited by 82
“Several studies investigating a role for autophagy during necroptotic signaling have showed increased lipidated LC3 (microtubuleassociated proteins 1A/1B light chain 3B) and other markers of autophagosomes during TNF-induced necroptosis (119, 136, 148, 149).”
BackgroundResult
Metadata
- Authors
- Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Yuan, Junying
- ORCID
- Venue
- Nature Chemical Biology
- Published
- 2005-05-29
- Volume
- 1
- Issue
- 2
- Pages
- 112-119
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2110796758
- Cited by
- 3,068
- References
- 39
- Citations by year
- 2026: 144 · 2025: 217 · 2024: 239 · 2023: 240 · 2022: 237 · 2021: 208 · 2020: 181 · 2019: 150 · 2018: 190 · 2017: 171 · 2016: 161 · 2015: 150 · 2014: 180 · 2013: 126 · 2012: 111
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Update notices
- addendum (2013-02-15)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- National Institute on Aging (R37AG012859)
- National Institute of General Medical Sciences (R01GM064703, R01 GM64703)
- National Institute of Neurological Disorders and Stroke (R01NS037141, R01 NS37141-08)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- necroptosis, non-apoptotic cell death, necrostatin-1, ischemic brain injury, stroke, neuroprotection, autophagy, regulated cell death, small molecule inhibitors
- MeSH terms
- Animals, Brain Ischemia, Humans, Imidazoles, Indoles, Molecular Structure, Signal Transduction, Cell Death, Protein Serine-Threonine Kinases, Cell Line, Tumor, Protein Kinase Inhibitors, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Mice, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.